Asia-Pacific Facial Injectables Market Report 2018

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Facial Injectables Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 Botulinum Toxin Market Performance (Volume)
  • 2.1.2 Hyaluronic Acid Market Performance (Volume)
  • 2.1.3 Collagen Market Performance (Volume)
  • 2.1.4 Particle & Polymer Fillers (PPF) Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.1.1 Botulinum Toxin Market Performance (Value)
  • 2.1.2 Hyaluronic Acid Market Performance (Value)
  • 2.1.3 Collagen Market Performance (Value)
  • 2.1.4 Particle & Polymer Fillers (PPF) Market Performance (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Hospitals Market Performance (Volume)
  • 3.1.2 Ambulatory Surgical Centers Market Performance (Volume)
  • 3.1.3 Cosmetic Centers Market Performance (Volume)
  • 3.1.4 Dermatology Clinics Market Performance (Volume)
  • 3.1.5 Physician Clinics Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Allergan
  • 4.1.1 Allergan Profiles
  • 4.1.2 Allergan Product Information
  • 4.1.3 Allergan Facial Injectables Business Performance
  • 4.1.4 Allergan Facial Injectables Business Development and Market Status
• 4.2 Prollenium Medical Technologies Inc
  • 4.2.1 Prollenium Medical Technologies Inc Profiles
  • 4.2.2 Prollenium Medical Technologies Inc Product Information
  • 4.2.3 Prollenium Medical Technologies Inc Facial Injectables Business Performance
  • 4.2.4 Prollenium Medical Technologies Inc Facial Injectables Business Development and Market Status
• 4.3 Galderma
  • 4.3.1 Galderma Profiles
  • 4.3.2 Galderma Product Information
  • 4.3.3 Galderma Facial Injectables Business Performance
  • 4.3.4 Galderma Facial Injectables Business Development and Market Status
• 4.4 Merz Aesthetics
  • 4.4.1 Merz Aesthetics Profiles
  • 4.4.2 Merz Aesthetics Product Information
  • 4.4.3 Merz Aesthetics Facial Injectables Business Performance
  • 4.4.4 Merz Aesthetics Facial Injectables Business Development and Market Status
• 4.5 Ipsen Group
  • 4.5.1 Ipsen Group Profiles
  • 4.5.2 Ipsen Group Product Information
  • 4.5.3 Ipsen Group Facial Injectables Business Performance
  • 4.5.4 Ipsen Group Facial Injectables Business Development and Market Status
• 4.6 Bloomage BioTechnology
  • 4.6.1 Bloomage BioTechnology Profiles
  • 4.6.2 Bloomage BioTechnology Product Information
  • 4.6.3 Bloomage BioTechnology Facial Injectables Business Performance
  • 4.6.4 Bloomage BioTechnology Facial Injectables Business Development and Market Status
• 4.7 Hangzhou Techderm Biological Products
  • 4.7.1 Hangzhou Techderm Biological Products Profiles
  • 4.7.2 Hangzhou Techderm Biological Products Product Information
  • 4.7.3 Hangzhou Techderm Biological Products Facial Injectables Business Performance
  • 4.7.4 Hangzhou Techderm Biological Products Facial Injectables Business Development and Market Status
• 4.8 Laboratory Obvieline
  • 4.8.1 Laboratory Obvieline Profiles
  • 4.8.2 Laboratory Obvieline Product Information
  • 4.8.3 Laboratory Obvieline Facial Injectables Business Performance
  • 4.8.4 Laboratory Obvieline Facial Injectables Business Development and Market Status
• 4.9 Medytox
  • 4.9.1 Medytox Profiles
  • 4.9.2 Medytox Product Information
  • 4.9.3 Medytox Facial Injectables Business Performance
  • 4.9.4 Medytox Facial Injectables Business Development and Market Status
• 4.10 Polymekon
  • 4.10.1 Polymekon Profiles
  • 4.10.2 Polymekon Product Information
  • 4.10.3 Polymekon Facial Injectables Business Performance
  • 4.10.4 Polymekon Facial Injectables Business Development and Market Status
• 4.11 Qufu Guanglong Biochem
• 4.12 Revitacare
• 4.13 Galderma
• 4.14 Merz Aesthetics
• 4.15 Ipsen Group

5 Market Performance for Manufacturers

• 5.1 Asia-Pacific Facial Injectables Sales (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 Asia-Pacific Facial Injectables Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 Asia-Pacific Facial Injectables Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 Asia-Pacific Facial Injectables Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 China Market Performance for Manufacturers
  • 6.1.1 China Facial Injectables Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.1.2 China Facial Injectables Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.1.3 China Facial Injectables Price (USD/Unit) of Manufacturers 2013-2018
  • 6.1.4 China Facial Injectables Gross Margin of Manufacturers 2013-2018
  • 6.1.5 Market Concentration
• 6.2 Japan Market Performance for Manufacturers
  • 6.2.1 Japan Facial Injectables Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.2.2 Japan Facial Injectables Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.2.3 Japan Facial Injectables Price (USD/Unit) of Manufacturers 2013-2018
  • 6.2.4 Japan Facial Injectables Gross Margin of Manufacturers 2013-2018
  • 6.2.5 Market Concentration
• 6.3 South Korea Market Performance for Manufacturers
  • 6.3.1 South Korea Facial Injectables Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.3.2 South Korea Facial Injectables Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.3.3 South Korea Facial Injectables Price (USD/Unit) of Manufacturers 2013-2018
  • 6.3.4 South Korea Facial Injectables Gross Margin of Manufacturers 2013-2018
  • 6.3.5 Market Concentration
• 6.4 Taiwan Market Performance for Manufacturers
  • 6.4.1 Taiwan Facial Injectables Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.4.2 Taiwan Facial Injectables Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.4.3 Taiwan Facial Injectables Price (USD/Unit) of Manufacturers 2013-2018
  • 6.4.4 Taiwan Facial Injectables Gross Margin of Manufacturers 2013-2018
  • 6.4.5 Market Concentration
• 6.5 India Market Performance for Manufacturers
  • 6.5.1 India Facial Injectables Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.5.2 India Facial Injectables Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.5.3 India Facial Injectables Price (USD/Unit) of Manufacturers 2013-2018
  • 6.5.4 India Facial Injectables Gross Margin of Manufacturers 2013-2018
  • 6.5.5 Market Concentration
• 6.6 Southeast Asia Market Performance for Manufacturers
  • 6.6.1 Southeast Asia Facial Injectables Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.6.2 Southeast Asia Facial Injectables Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.6.3 Southeast Asia Facial Injectables Price (USD/Unit) of Manufacturers 2013-2018
  • 6.6.4 Southeast Asia Facial Injectables Gross Margin of Manufacturers 2013-2018
  • 6.6.5 Market Concentration
• 6.7 Australia Market Performance for Manufacturers
  • 6.7.1 Australia Facial Injectables Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.7.2 Australia Facial Injectables Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.7.3 Australia Facial Injectables Price (USD/Unit) of Manufacturers 2013-2018
  • 6.7.4 Australia Facial Injectables Gross Margin of Manufacturers 2013-2018
  • 6.7.5 Market Concentration
• 6.8 Market Performance for Manufacturers
  • 6.8.1 Facial Injectables Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.8.2 Facial Injectables Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.8.3 Facial Injectables Price (USD/Unit) of Manufacturers 2013-2018
  • 6.8.4 Facial Injectables Gross Margin of Manufacturers 2013-2018
  • 6.8.5 Market Concentration

7 Asia-Pacific Facial Injectables Market Performance (Sales Point)

• 7.1 Asia-Pacific Facial Injectables Sales (K Units) and Market Share by Regions 2013-2018
• 7.2 Asia-Pacific Facial Injectables Revenue (M USD) and Market Share by Regions 2013-2018
• 7.3 Asia-Pacific Facial Injectables Price (USD/Unit) by Regions 2013-2018
• 7.4 Asia-Pacific Facial Injectables Gross Margin by Regions 2013-2018

8 Development Trend for Regions (Sales Point)

• 8.1 Asia-Pacific Facial Injectables Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.2 China Facial Injectables Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.3 Japan Facial Injectables Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.4 South Korea Facial Injectables Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.5 Taiwan Facial Injectables Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.6 India Facial Injectables Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.7 Southeast Asia Facial Injectables Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Australia Facial Injectables Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Australia Facial Injectables Sales and Growth, Sales Value and Growth Rate2013-2018

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Hospitals Industry
• 11.2 Ambulatory Surgical Centers Industry
• 11.3 Cosmetic Centers Industry

12 Market Forecast 2019-2024

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 12.1.1 Asia-Pacific Facial Injectables Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 12.1.2 Asia-Pacific Facial Injectables Sales (K Units) and Growth Rate 2019-2024
  • 12.1.3 China Facial Injectables Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.4 Japan Facial Injectables Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.5 South Korea Facial Injectables Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.6 Taiwan Facial Injectables Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.7 India Facial Injectables Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.8 Southeast Asia Facial Injectables Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.9 Australia Facial Injectables Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.10 Facial Injectables Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
  • 12.3.1 Overall Market Performance
  • 12.3.2 Botulinum Toxin Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.3 Hyaluronic Acid Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.4 Collagen Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.5 Particle & Polymer Fillers (PPF) Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.4 Sales by Application 2019-2024
  • 12.4.1 Overall Market Performance
  • 12.4.2 Hospitals Sales and and Growth Rate 2019-2024
  • 12.4.3 Ambulatory Surgical Centers Sales and and Growth Rate 2019-2024
  • 12.4.4 Cosmetic Centers Sales and and Growth Rate 2019-2024
  • 12.4.5 Dermatology Clinics Sales and and Growth Rate 2019-2024
• 12.5 Price (USD/Unit) and Gross Profit
  • 12.5.1 Asia-Pacific Facial Injectables Price (USD/Unit) Trend 2019-2024
  • 12.5.2 Asia-Pacific Facial Injectables Gross Profit Trend 2019-2024

13 Conclusion